deltatrials
Unknown PHASE3 INTERVENTIONAL 3-arm NCT00774826

Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma

Phase III Multicentric IIL Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Treatment of Patients With Stage II-IV Follicular Lymphoma

Sponsor: Fondazione Italiana Linfomi - ETS

Updated 8 times since 2017 Last updated: Feb 14, 2011 Started: Dec 31, 2005 Primary completion: Sep 30, 2010 Completion: Mar 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Follicular Lymphoma, this trial is ongoing. The trial is conducted by Fondazione Italiana Linfomi - ETS and has accumulated 8 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Sep 2020 · 27 months · monthly snapshotUnknown Status~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotUnknown Status~Jan 2021 – ~Jun 2023 · 29 months · monthly snapshotUnknown Status~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 11 months · monthly snapshotUnknown

Change History

8 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown StatusUnknown

  4. Jun 2023 — Jul 2024 [monthly]

    Unknown Status PHASE3

  5. Jan 2021 — Jun 2023 [monthly]

    Unknown Status PHASE3

Show 3 earlier versions
  1. Sep 2020 — Jan 2021 [monthly]

    Unknown Status PHASE3

  2. Jun 2018 — Sep 2020 [monthly]

    Unknown Status PHASE3

  3. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    First recorded

Dec 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fondazione Italiana Linfomi - ETS
Data source: Fondazione Italiana Linfomi - ETS

For direct contact, visit the study record on ClinicalTrials.gov .